Microfluidic Device System Market Overview
The global Microfluidic Device System market is expected to rise at a considerable rate in the forthcoming years. The life science and pharmaceutical industries have been enthralled by the advancements of microfluidic components and technologies in recent years. Furthermore, various developing analytical applications in a variety of end-user industries are predicting further advancements. Engineering microminiaturized medical equipment has relied heavily on this technology. Though this technology has a wide range of applications, microfluidic components have become increasingly popular in the development of lab-on-a-chip systems.
Furthermore, the microfluidic components have several advantages, including being inexpensive and providing quick test results, which has increased their importance in biological and chemical studies. Advances in point-of-care testing are projected to broaden the scope of microfluidic device applications. The low cost of diagnostic methods and the minimal usage of reagents are two more advantages of microfluidic components and instruments. Recently, the microfluidic device system has seen a slew of promising applications in the fields of proteomics and genomics, opening up a slew of new potential for market participants. Each of these factors is anticipated to have a definite impact on the Microfluidic Device System market during the forecast period.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Application, Industry Type, Material, and Region |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Abbott Laboratories, Becton Dickinson and Company, Siemens Healthcare, Agilent Technologies, Fluidigm Corporation, Roche Diagnostics, Bio-Rad Laboratories. |
Covid-19 Impact on Microfluidic Device System Market
In addition, the current Microfluidic Device System Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Microfluidic Device System Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long-term as well as short-term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Microfluidic Device System Market Segment Overview
According to Applications, the Clinical and Veterinary Diagnostic segment held the largest share in the Microfluidic Device System market. However, the point of care testing segment could show a notable growth rate in the global microfluidic device system market in the forecast period. Based on the Industry Type, In-Vitro Diagnostics is one of the most prominent segments in the market. In-Vitro Diagnostics is the largest user of microfluidic device systems. Furthermore, during the forecast period, the medical devices segment is also estimated to rise the use of microfluidic device systems that may boost the demand in the market.
Microfluidic Device System Market, By Application
· Pharmaceuticals and Life Science
· Drug Delivery
· Clinical and Veterinary Diagnostics
· Analytical Devices
· Environmental and Industrial
· Point Of Care Testing
Microfluidic Device System Market, By Industry Type
· Pharmaceuticals
· In-Vitro Diagnostics
· Medical Devices
Microfluidic Device System Market, By Material
· Glass
· Polymer
· Silicon
Microfluidic Device System Regional Overview
Geographically, North America commanded a major share of the market and is predictable to maintain its supremacy over the forecast period. The region's microfluidic device system market is expected to rise due to the increasing development of purpose-oriented and novel microfluidic device systems. Meanwhile, medical device demand is mostly increasing in the Asia Pacific, with point-of-care testing being the fastest-growing application in the microfluidic device system market. Asia Pacific is expected to grow at a healthy CAGR over the predicted period. The introduction of low-cost and portable microfluidic platforms in point-of-care testing in several emerging economies is assisting the market's expansion.
Microfluidic Device System Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Microfluidic Device System Market, Key Players
· Abbott Laboratories
· Becton Dickinson and Company
· Siemens Healthcare
· Agilent Technologies
· Fluidigm Corporation
· Roche Diagnostics
· Bio-Rad Laboratories
Frequently Asked Questions (FAQ) :
Q1. Which Segments are covered in the Microfluidic Device System Market report?
Application, Industry Type, Material, and Region these segments are covered in the Microfluidic Device System market report.
Q2. Which segment is projected to hold the largest share in the Microfluidic Device System Market?
Clinical and Veterinary Diagnostic segment is projected to hold the largest share in the Microfluidic Device System Market.
Q3. Which are the parts of the Industry Type segment in the Microfluidic Device System market?
Pharmaceuticals, In-Vitro Diagnostics, Medical Devices are parts of the Industry Type segment in the Microfluidic Device System market
Q4. Which region holds the largest share in the Microfluidic Device System market?
North America held the largest share in the global Microfluidic Device System market.
Q5. Which are the prominent players in the Microfluidic Device System Market?
Abbott Laboratories, Becton Dickinson and Company, Siemens Healthcare, Agilent Technologies, Fluidigm Corporation, Roche Diagnostics, Bio-Rad Laboratories are some key players in the Microfluidic Device System Market.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Microfluidic Device System Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Pharmaceuticals and Life Science
- 5.2.2. Drug Delivery
- 5.2.3. Clinical and Veterinary Diagnostics
- 5.2.4. Analytical Devices
- 5.2.5. Environmental and Industrial
- 5.2.6. Point Of Care Testing
- 5.3. Market Analysis, Insights and Forecast – By Industry Type
- 5.3.1. Pharmaceuticals
- 5.3.2. In-Vitro Diagnostics
- 5.3.3. Medical Devices
- 5.4. Market Analysis, Insights and Forecast – By Material
- 5.4.1. Glass
- 5.4.2. Polymer
- 5.4.3. Silicon
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Microfluidic Device System Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Pharmaceuticals and Life Science
- 6.2.2. Drug Delivery
- 6.2.3. Clinical and Veterinary Diagnostics
- 6.2.4. Analytical Devices
- 6.2.5. Environmental and Industrial
- 6.2.6. Point Of Care Testing
- 6.3. Market Analysis, Insights and Forecast – By Industry Type
- 6.3.1. Pharmaceuticals
- 6.3.2. In-Vitro Diagnostics
- 6.3.3. Medical Devices
- 6.4. Market Analysis, Insights and Forecast – By Material
- 6.4.1. Glass
- 6.4.2. Polymer
- 6.4.3. Silicon
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Microfluidic Device System Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Pharmaceuticals and Life Science
- 7.2.2. Drug Delivery
- 7.2.3. Clinical and Veterinary Diagnostics
- 7.2.4. Analytical Devices
- 7.2.5. Environmental and Industrial
- 7.2.6. Point Of Care Testing
- 7.3. Market Analysis, Insights and Forecast – By Industry Type
- 7.3.1. Pharmaceuticals
- 7.3.2. In-Vitro Diagnostics
- 7.3.3. Medical Devices
- 7.4. Market Analysis, Insights and Forecast – By Material
- 7.4.1. Glass
- 7.4.2. Polymer
- 7.4.3. Silicon
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Microfluidic Device System Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Pharmaceuticals and Life Science
- 8.2.2. Drug Delivery
- 8.2.3. Clinical and Veterinary Diagnostics
- 8.2.4. Analytical Devices
- 8.2.5. Environmental and Industrial
- 8.2.6. Point Of Care Testing
- 8.3. Market Analysis, Insights and Forecast – By Industry Type
- 8.3.1. Pharmaceuticals
- 8.3.2. In-Vitro Diagnostics
- 8.3.3. Medical Devices
- 8.4. Market Analysis, Insights and Forecast – By Material
- 8.4.1. Glass
- 8.4.2. Polymer
- 8.4.3. Silicon
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Microfluidic Device System Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Pharmaceuticals and Life Science
- 9.2.2. Drug Delivery
- 9.2.3. Clinical and Veterinary Diagnostics
- 9.2.4. Analytical Devices
- 9.2.5. Environmental and Industrial
- 9.2.6. Point Of Care Testing
- 9.3. Market Analysis, Insights and Forecast – By Industry Type
- 9.3.1. Pharmaceuticals
- 9.3.2. In-Vitro Diagnostics
- 9.3.3. Medical Devices
- 9.4. Market Analysis, Insights and Forecast – By Material
- 9.4.1. Glass
- 9.4.2. Polymer
- 9.4.3. Silicon
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Abbott Laboratories
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Becton Dickinson and Company
- 10.6. Siemens Healthcare
- 10.7. Agilent Technologies
- 10.8. Fluidigm Corporation
- 10.9. Roche Diagnostics
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
